ADMA Biologics Debt To Assets Over Time

ADMA Stock

USD 17.40 0.50 2.79%

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.

Check out ADMA Biologics Performance and ADMA Biologics Correlation.

For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.

As of December 22, 2024, Debt To Assets is expected to decline to 0.38.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

Earnings Share

0.27

Revenue Per Share

1.661

Quarterly Revenue Growth

0.781

Return On Assets

0.1989

The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Specify up to 10 symbols:

Apply

Cross Equities Debt To Assets Analysis

Compare ADMA Biologics and related stocks such as Atara Biotherapeutics, Fate Therapeutics, and Sana Biotechnology Debt To Assets Over Time

Select Fundamental

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
ATRA	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FATE	0.6163	0.6163	0.3316	0.0312	0.3833	0.2684	0.1124	0.1406	0.0699	0.0056	0.0054	0.0061	0.008	0.0122	0.0116
SANA	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0985	0.0982	0.1316	0.12	0.088
CRBU	0.0086	0.0086	0.0086	0.0086	0.0086	0.0086	0.0086	0.0086	0.0086	0.0086	0.0438	0.0026	0.0026	0.003	0.0028
RCUS	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFFP	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0069	0.0041
INMB	0.775	0.775	0.775	0.775	0.775	0.775	0.775	0.1454	0.1454	0.1454	0.1454	0.1454	0.1807	0.1761	0.35
ANEB	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0665	0.0598	0.0532
ANTX	0.1277	0.1277	0.1277	0.1277	0.1277	0.1277	0.1277	0.1277	0.1277	0.1277	5.0E-4	5.0E-4	5.0E-4	6.0E-4	6.0E-4
ETNB	0.147	0.147	0.147	0.147	0.147	0.147	0.147	0.147	0.147	0.1194	0.1194	0.1194	0.1009	0.0424	0.0403
MDGL	0.0041	0.3927	0.1204	0.2449	0.1377	0.7126	7.0E-4	7.0E-4	7.0E-4	7.0E-4	0.0011	0.0015	0.1359	0.1811	0.12
PLRX	0.0079	0.0079	0.0079	0.0079	0.0079	0.0079	0.0079	0.0079	0.0079	0.0037	0.0084	0.0084	0.0353	0.0222	0.0124
ACLX	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0012	0.0011	9.0E-4
STOK	1.23	1.23	1.23	1.23	1.23	1.23	1.23	1.23	0.0014	0.0014	0.0014	0.0014	0.0014	0.0016	0.0016
PLX	0.0134	0.5916	0.5916	0.5916	0.8597	0.7413	0.9425	0.7227	0.7846	1.2174	0.8613	0.395	0.5253	0.2565	0.49
CDTX	7.3781	7.3781	7.3781	7.3781	0.0916	0.0916	0.0916	0.1249	0.1255	0.1563	0.1318	0.0496	0.0194	0.0223	0.0212
AKBA	0.0151	0.0151	0.0151	0.0151	0.0151	0.0151	0.0151	0.0151	0.0151	0.0983	0.1496	0.1856	0.3512	0.3754	0.39
XFOR	0.7564	0.7564	0.7564	0.7564	0.7564	0.7564	2.0071	0.1506	0.2661	0.1306	0.2764	0.2988	0.2238	0.378	0.55
MCRB	0.3944	0.3944	0.3944	0.3944	0.0213	0.2198	0.2198	0.2198	0.2198	0.2198	0.0732	0.0881	0.1464	0.3018	0.2
IBIO	0.0033	0.0033	0.0033	0.0033	0.0033	0.0033	0.0051	0.0046	0.007	0.0096	0.0066	0.2229	0.314	0.0342	0.054
TNXP	4.8772	4.8772	0.0321	0.0321	0.0577	0.0577	0.0577	0.0577	0.0577	0.0577	0.0577	0.0577	0.0577	0.0663	0.063
BCRX	0.0703	0.3649	0.5223	0.6139	0.2192	0.2232	0.5679	0.2911	0.4023	0.4557	0.82	0.9954	1.3332	1.5693	1.65

ADMA Biologics and related stocks such as Atara Biotherapeutics, Fate Therapeutics, and Sana Biotechnology Debt To Assets description

My Equities

My Current Equities and Potential Positions

View All Next

ADMA Biologics

ADMA

Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Location	New Jersey; U.S.A
Exchange	NASDAQ Exchange

USD 17.4

When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:

How To Invest In ADMA

Details

Is ADMA Stock a good investment?

Details

What is ADMA Biologics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out ADMA Biologics Performance and ADMA Biologics Correlation.

For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of ADMA Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ADMA Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

ADMA Biologics Debt To Assets Over Time

Specify up to 10 symbols:

Cross Equities Debt To Assets Analysis

ADMA Biologics and related stocks such as Atara Biotherapeutics, Fate Therapeutics, and Sana Biotechnology Debt To Assets description

My Equities

My Current Equities and Potential Positions

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY